Mitralign Garners $8,053,717 New Financing

  • Feed Type
  • Date
    6/20/2014
  • Company Name
    Mitralign
  • Mailing Address
    3 Highwood Drive Tewksbury, MA 01876 USA
  • Company Description
    We are currently developing an innovative, catheter- based mitral valve repair system that not only provides an alternative to open heart surgery but emulates the traditional surgical repair technique. The condition treated,mitral valve regurgitation (MR), is common in patients with Congestive Heart Failure.
  • Website
    http://www.mitralign.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $8,053,717
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy